Health. Areas and opportunities for internationalisation of the Catalan health industry by Mayolas, Enric
A_20_Mayolas_176-183.qxp:N4  28/6/10  16:54  Página 176
Health
Areas and opportunities for
internationalisation of the
Catalan health industry
Based on the potential of the health industry, its traditional
openness and drive for going abroad, internationalisation
experiences and a Mediterranean mindset that may create new
opportunities, this article introduces several experiences of some
institutions and companies from the Catalan health industry.
ENRIC MAYOLAS
Case studies: Fundació Clínic/CRESIB/Centre de Recerca de Manhiça, Consorci 
Hospitalari de Catalunya (CHC), Gesaworld, Pinearq, Banc de Sang i de Teixits 
de Catalunya (BSTC), Bergadana, BioRegió de Catalunya (Biocat)
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The Union for the
Mediterranean, an
opportunity to seize
Barcelona has been hosting the Union for the
Mediterranean (UM) for a few months now, by
which the city is finally acknowledged as the
capital of the Mediterranean. The step in
obtaining this recognition has been done, but
now comes perhaps the most difficult: acting as
a capital after being recognised as such, and
with regards to health, this means to open our
possibilities and reality to the rest of countries.
Saying that Barcelona is the biomedical capital of
the Mediterranean and not having almost any
website in French, the vehicular language of most
countries on the southern rim, and a very scarce
presence in English makes it hard to be acknowl-
edged as a reference where these countries may
feel at home, to which French and Arab are the
languages to communicate abroad. It may seem a
minor fact, but implementing action as basic as this
shows in how far we wish to play a role in health,
cooperation, technical aid, capacity of attracting
patients from the Francophone area and become
the reference for the Mediterranean region.
Efforts need to be done to increase
the ability of our companies and
institutions to interact in the region
to provide a stronger footprint in
expertise, experience and capacity
we are supposed to have and we
now need to apply firmly and
generously.
Efforts need to be done to increase the ability
of our companies and institutions to interact in
the region to provide a stronger footprint in
expertise, experience and capacity we are sup-
posed to have and we now need to apply firmly
and generously. This item is key in developing
the health area in the UM. It is obvious that we
have the best capacities to be relevant in 
the region, but the predominant position in the
industry can be easily gained by companies
from other countries informed about the value
and expertise of our people, and if they hire
them it may provide them an advantage 
for their traditional and often consolidated
presence in this area.
It is interesting to explain the experience of




It is very important to point out the important
of ongoing presence in Morocco by the Fun-
dació Clínic due to the role it has played,
together with the Spanish International Coopera-
 tion Agency (AECI) in running a hospital in the
North of the country and having become a
partner for different training actions. It led
more recently a mother-child health project
together with the Moroccan Ministry of Health.
This continuity is a key to open doors and be 
a preferred player in the Moroccan health
reform process, in which the Catalan experi-
ence can be so useful.
In Manhiça, Mozambique, professionals from
the Fundació Clínic have created an excellence
research centre, with the assistance of AECI, 
the Government of Catalonia and private foun-
dations, to develop a malaria vaccine among
others.
This experience has allowed setting up a struc-
ture like the Global Health Observatory, a cru-
cial tool to exert leadership from Barcelona in
health policies for the Mediterranean region.
This is a clear example in which excellent, polit-
ical will at all levels, cooperation of big private
institutions, persistency and continuity have
born their fruits. Such action needs to be con-
tinued to have all-round tools allowing partici-
pation of other business areas.
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Health tourism
Internationalisation of the health service provi-
sion industry is basically focused on attracting
patients to Barcelona. This has a long tradition
connected with the historical attractiveness of
some centres like the Barraquer and Puigvert
clinics, being now part of Barcelona Centre
Mèdic (BCM) for over twenty years. This associ-
ation gathers twenty renowned centres, both
private and from the public network: tertiary
hospitals, general and specialist private clinics,
image diagnose centres and clinical labs. Note-
worthy is also Barnaclínic, the private offer of
the Hospital Clínic, as well as other individual
initiatives of some centres.
We have an enormous capital and
big possibilities, but only if playing
them together. Fragmentation in the
offer, wrong pricing policies and
lack of common strategies will
doom us to limited results.
Such wrongly named «health tourism», which is
in fact made of travelling patients, has become an
outright market that has been quickly developing
and structuring in recent years despite being still
immature. Specific channels, trade shows and
markets have been created, players defined, rules
of the game set, etc.
It became obvious that either you have a global
brand or you need to operate as a destination.
Today, Barcelona can aspire to become a desti-
nation and be recognised as a quality medical
pole, but this needs to be done by others, it is
not enough to tell it to and among ourselves.
We have good chances if we submit a global
wide offer and address markets with good
accessibility (the airport will set the pace here),
with competitive prices and proven quality. 
In this respect, obtaining quality certification for
our centres as recognised at international level
will become indispensable.
Almost fifty destinations all over the world
have entered this market, some in Spain, 
like Marbella-Costa del Sol and more recently
Madrid. At regional level, Turkey and Jordan,
with health cluster initiatives enjoying strong
institutional support, have become success sto-
ries and a business reality.
Being competitive in this field can only be
achieved if we accept the rules of this new
business and play in full accordance with them.
We have an enormous capital and big possibili-
ties, but only if playing them together. Frag-
mentation in the offer, wrong pricing policies
and lack of common strategies will doom us to
limited results, which can be still relevant for
the one or other centre but will not place
Barcelona where we could place it in the inter-
national health care market.
In terms of service types able to attract
patients, it seems that it is the more complex
processes done at acute centres the ones able
to be better commercialised abroad, as their
high cost can generate room for setting price
competition. There are also other areas that
may attract patients based on legal restrictions
existing in some countries for certain opera-
tions, higher technological progress or ability
to keep confidentiality.
Awareness needs to be raised that this is a
business with a great economic potential. This
shall allow to obtain institutional political sup-
port (departments of Health and Innovation,
Universities and Enterprise, Barcelona City
Council) as our competitors do and firm com-
mitment by health service suppliers as well as
local operators (tourist services).
Another key element for success is cooperation
by consular authorities. EU member states with
cities competing with Barcelona in attracting
patients from outside the EU offer all facilities
to obtain visa to enter the country within 24-48
hours. As opposed to it, many obstacles are
observed in giving visa to travel to Barcelona,
and Spanish consular authorities are hardly
sensitive towards such cases. There is not the
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view that this is a very important business for
both Catalonia and Spain.
It is only with all support that we can aspire to
develop this business and place Barcelona as a
destination able to live up to its full potential.
International public
procurement
Procurement of any kind of goods and services
by public organisations is a very important part
of demand in a country, with a volume between
15 and 20% of gross domestic product (GDP)
in most of them. According to estimates by the
Organisation of Economic Co-operation and
Development (OECD), roughly one third of
public procurement can be opened to interna-
tional trade. However, there are national obsta-
cles to opening it to foreign suppliers, by which
the most significant portion of international
public procurement is associated with official
development aid (ODA), in which health plays
a leading role. Between 1997 and 2007, global
resources for procurement and selling goods
and services to the public sector regarding
health increased 16.7% a year, compared to
11.1% for overall ODA.
Taking part in these projects
requires deep knowledge of tender
mechanisms, a strategy going
beyond immediacy and institutional
activity aimed at creating links and
developing cooperation agreements
in support of the internationalisation
strategy of the health industry.
The rise of international development projects
in health provide interesting internationalisation
opportunities for the Catalan health industry.
Taking part in these projects requires deep
knowledge of tender mechanisms beyond techni-
cal capacity, a strategy going beyond immediacy
and, as we said before, institutional activity
aimed at creating links and developing coopera-
tion agreements in support of the internationali-
sation strategy of the health industry. Foreign
visibility, reputation and presence in contracting
countries is necessary, together with successful
links and agreements with local partners.
Catalan consulting firms have successfully par-
ticipated in many tenders, especially in Latin
America. The creation of a trust at the Interna-
tional Finance Corporation of the World Bank for
ACC1Ó means having a very useful tool to
facilitate participation of Catalan companies in
multilateral tendering.
I would now like to look into some Catalan
experiences.
Consorci Hospitalari de Catalunya 
(CHC)
In the mid 1990s, this entrepreneurial associa-
tion initiated a process to participate in tenders
for technical aid and health system reform in
many Latin American countries, placing the
Catalan health system as a reference. The CHC
has been given dozens of projects funded by
the World Bank and the Inter-American Devel-
opment Bank.
It has further participated in designing hospital
projects in public-private partnerships (PPP)
done by other entrepreneurial conglomerates
from outside Catalonia, in which it provides
technical aid or assessment. However, this did
not bring about the expected dragging effect,
like building facilities, selling equipment, infor-
mation systems, etc.
We need to be proud of a clear success that
has contributed significantly to placing the
Catalan system among the leading in the
world, although business opportunities cre-
ated by this have not been consolidated. 
A relevant role may play the fact of not having
banks nor building companies interested in
those markets.
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Having a very long reference list of projects for
multilateral institutions is an enormous capital
few organisations can boast. This list provides a
huge competitive advantage to apply for new
contracts, considering the necessary expertise
we have.
Gesaworld
Gesaworld is an international company special-
ising in health management and social service
consulting created with similar objectives and
target markets, plus a relevant footprint in Por-
tugal. Development of specific products and
ongoing and persistent presence in some mar-
kets have allowed it to run many multilateral
projects as well as some funded by govern-
ments on a bilateral basis. Deployment of a
subsidiary network in the main Latin American
markets provides a footprint and visibility
allowing it to tackle ambitious global projects
like building hospitals.
Pinearq
Pinearq is a landmark architecture studio in
Catalonia and Spain for health projects, espe-
cially hospitals. After having built many facili-
ties there, it took up projects abroad, in Europe
as well as on other continents. This is another
case of joint experience and expertise with a
high potential for international development.
Banc de Sang i de Teixits de Catalunya
(BSTC)
This is a public-private partnership pooling
Catalan blood banks and developing production
of plasma derivatives with private cooperation.
BSTC is a clear example of an experience that
raises considerable interest in the process –
bringing together blood banks and doing single
multi-centred management – as well as allow-
ing cost reduction and maintenance, sharing
expertise with private initiative and making a
successful business. BSTC has taken part in
advisory action in Brazil, Argentina, Portugal,
etc. Its potential is enormous.
BSTC is a clear example of an
experience that raises considerable
interest in the process as well as
allowing cost reduction and
maintenance, sharing expertise with
private initiative and making a
successful business.
Bergadana
Adaptation of health transport vehicles to 
create a competitive high-quality product with
a strong international mindset led this Catalan
company to sell vehicles all over the world and
create strong relations with many health
authorities. It has thus become a leading com-
pany based on its own strategy. These special
relations have not joined other initiatives. 
On the one hand, it is logical that each com-
pany or group defends its positions, but on 
the other, they have not been able to cross-
strengthen them in order to consolidate the
international footprint of the Catalan health
industry as they were not aware of it.
Public-private partnerships
This sort of projects has become commonplace in
many emerging economies after their origin in
the United Kingdom. They are based on a long-
term service concession, often thirty years. They
involve investment to build infrastructures, in this
case related with health, and are reimbursed
through service provision. Restrictions to public
debt are the cause of their proliferation.
Business groups and consortia taking the finan-
cial risk of the operation need to be created to
participate, by which companies join to do all
activities needed to create the infrastructure
and often also run the facilities and provide
health services.
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Catalan presence in this emerging market has
been very reduced and not at all in line with
the experience and capacity the relevant players
have historically shown in Catalonia. Many
other Spanish players have in turn appeared in
these markets.
This sort of project can become however a
strategic industry as it encompasses most 
subsectors within the health sector, from
investment to the different areas of knowledge
management and support service provision.
Experiences deployed in Catalonia could be 
the germ to start participating in international
initiatives.
The Catalonia BioRegion (Biocat)
Since its creation in 2006, Biocat, an organisa-
tion promoted by the Government of Catalonia
and the Barcelona City Council, coordinates and
fosters biotechnology, biomedicine and medical
technologies in Catalonia. It encompasses rep-
resentative companies and organisations from
the industry with a total 350 companies, sixty 
of which deal with biotechnology strictly
speaking. Oncology, genomics and nervous 
system diseases are the research priorities.
The current economic crisis often raises the
question about keeping many research initia-
tives under budget constraints affecting
research funds, although the government is
decided in maintaining and if possible increas-
ing activity.
Its international partnership policy
has placed the Catalan BioRegion,
participating in the Southern Europe
biocluster, as a strategic item for
internationalisation of the industry.
The size and diversity of facilities and their
geographic spread raise many concerns regard-
ing concentration of efforts to reach a bigger
size. Catalonia has been able to take a vantage
position in regenerative medicine and oncol-
ogy. Its international partnership policy has
placed the Catalan BioRegion, participating 
in the Southern Europe biocluster, as a strate-
gic item for internationalisation of the industry.
To conclude with
Catalonia has an enormous potential in the
biomedical industry thanks to its historic and
current capacities.
It is obvious that when referring to this indus-
try, there are many sorts of activities and sub-
sectors involved, so beyond one common global
brand and mindset there are different interna-
tionalisation strategies.
All subsectors have and show a clear push for
internationalisation and some lack a thorough
structure to tackle it.
Presence in international markets is irregular
and very focused on Latin America. A strategy
for a footprint in Asia needs to be created. As
far as health is concerned, Africa has a low
business profile.
To place Catalonia-Barcelona as a biomedical
destination, cross-relations of the different
subsectors need to be fostered and all existing
international advantages and success stories 
in each area used. The brand needs to be
pushed from all its sides. Research cannot
leave aside the success and milestones reached
by health care and health policies. Catalonia
will become a destination attracting interna-
tional patients if it recognises itself as a
research centre and be able to attract more tal-
ent and business if this mindset is persistent
and consistent with devoted time and
resources.
Acting as the capital of the Mediterranean and
taking advantage of the potential provided by
hosting the UM headquarters shall be a com-
mon goal for which institutions and companies
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need to show their will and effort. A health
industry cluster – like the ones in Boston,
Turkey and Korea – needs to be created, bring-
ing together the different subsectors and being
a tool at the service of its foreign relations. It
shall allow strengthening this industry in a
wide and general sense and consolidating the
Catalonia-Barcelona brand as an area with
integrated, powerful and competitive biomed-
ical activity. Everything necessary is in place,
and there are even some territories having the
same with less resources, and yet they have
been successful. However, Catalonia does not
have it all: the difference is in the detail and the
way of doing things, and here the detail may lie
in the generous capacity of working together in
a responsible and ambitious way by all involved
in the industry.
To place Catalonia-Barcelona as a
biomedical destination, cross-
relations of the different subsectors
need to be fostered and all existing
international advantages and
success stories in each area used.
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